Bates College

Autolus Therapeutics Announces Changes to its Board of Directors

Retrieved on: 
Monday, April 1, 2024
Cubist Pharmaceuticals, DBV Technologies, MB, Alnylam Pharmaceuticals, Harvard Medical School, University of Cambridge, Faculty, Imperial College London, Development, GSK plc, Biologics license application, Hematology, Patient, ALL, Merck, Bristol Myers Squibb, Marketing, Biogen, Doctor of Philosophy, Bates College, Oxford Biomedica, Sarepta Therapeutics, Pharmaceutical medicine, Therapy, Swedish Orphan Biovitrum, Royal college, FDA, BLA, Autoimmunity, Economics, Food, Pharmaceutical industry

John H. Johnson advised the Board of his decision to step down from his role as Chairman of the Board and Non-Executive Director.

Key Points: 
  • John H. Johnson advised the Board of his decision to step down from his role as Chairman of the Board and Non-Executive Director.
  • We wish John much success with his new projects,” said Dr. Christian Itin, Chief Executive Officer of Autolus.
  • He is currently a director of Alnylam Pharmaceuticals and chair of Dunad Therapeutics and Gulf of Maine Research Institute.
  • Mr. Bonney has served as a director with many companies previously including Celgene, Kaleido Biosciences, Magenta Therapeutics, Bristol Myers Squibb, Sarepta Therapeutics and Syros Pharmaceuticals.

Eterna Therapeutics Appoints James Bristol, Ph.D., Pharmaceutical Research and Drug Discovery Veteran, to Board of Directors

Retrieved on: 
Wednesday, November 1, 2023
ERNA, Bates College, Organic chemistry, Drug discovery, Publication, Schering-Plough, Research, University, Drug development, Retirement, Abstract, Messenger, Senior advisor, Bristol, Patient, Doctor of Philosophy, United States Air Force Scientific Advisory Board, Parke-Davis, Pharmaceutical industry, Eterna, Pfizer, Chemistry

Bristol is a seasoned biopharmaceutical executive who has excelled as a corporate partner, board member, and strategic and technical advisor within our industry,” said Matt Angel, Ph.D., Chief Executive Officer and President of Eterna.

Key Points: 
  • Bristol is a seasoned biopharmaceutical executive who has excelled as a corporate partner, board member, and strategic and technical advisor within our industry,” said Matt Angel, Ph.D., Chief Executive Officer and President of Eterna.
  • Before that, he worked at Parke-Davis for 20 years, where he held positions of increasing responsibility in Chemistry and Drug Discovery and participated in collaboration oversight committees.
  • Early in his career, Dr. Bristol was a Principal Scientist at Schering-Plough, leading the gastrointestinal research program.
  • His drug discovery research has resulted in numerous publications, abstracts, and patents.

Arbutus Appoints Two New Executives

Retrieved on: 
Monday, July 10, 2023
KRYS, Employment, University, Therapy, General counsel, Willamette University College of Law, HIV, Virology, Liz, Van Sweringen railroad holdings, Infection, Drug, Viral, Bristol Myers Squibb, Koch Industries, Doctor of Philosophy, Bates College, Assistant, BMY, Hospital of the University of Pennsylvania, Arbutus, Lung transplantation, Medical director, Patent, MD, Patient, Internal medicine, Oklahoma Office of the Chief Medical Examiner, Corporation, RNA interference, Hospital, Blank Rome, HCV, Hampden–Sydney College, HBV, NYSE, Behavioral neuroscience, Compensated emancipation, Pharmaceutical industry, Neuroscience, Medicine

WARMINSTER, Pa., July 10, 2023 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop novel therapeutics that target specific viral diseases, today announced the appointment of Dr. Karen Sims as Chief Medical Officer and Mr. Christopher Naftzger as General Counsel and Chief Compliance Officer. Mr. Naftzger succeeds Dr. Elizabeth Howard who will continue in an advisory role with respect to the on-going patent infringement litigations. Both Dr. Sims and Mr. Naftzger will report directly to William Collier, Arbutus President and Chief Executive Officer, effective immediately.

Key Points: 
  • Both Dr. Sims and Mr. Naftzger will report directly to William Collier, Arbutus President and Chief Executive Officer, effective immediately.
  • “Karen has played an integral role in the clinical development of AB-729, our lead RNAi therapeutic, during her six-year tenure at Arbutus, and has continued to advance our pipeline of HBV programs.
  • Prior to joining Arbutus, Dr. Sims held multiple positions during her seven-year tenure at Bristol-Myers Squibb (NYSE: BMY).
  • Christopher Naftzger joins Arbutus with more than 25 years of legal experience, including over a decade of experience serving as senior in-house counsel with life science companies.

GoldenTree Asset Management Announces Alysia Love as Chief Talent Officer

Retrieved on: 
Thursday, July 6, 2023
Asset Management, Professional Services, Finance, Morgan Stanley, Love, CFA, Partner (business rank), Multimedia, Bates College, Organization, GoldenTree Asset Management, Acquisition, Partner, Executive Committee, Harvard Business School, Growth, Central Executive Committee (PAP), Hewlett-Packard, Management, Alysia

GoldenTree Asset Management (“GoldenTree”), a global asset management firm with over $50 billion in assets under management, announced the addition of Alysia Love as Chief Talent Officer and Partner today.

Key Points: 
  • GoldenTree Asset Management (“GoldenTree”), a global asset management firm with over $50 billion in assets under management, announced the addition of Alysia Love as Chief Talent Officer and Partner today.
  • View the full release here: https://www.businesswire.com/news/home/20230706468509/en/
    Alysia Love, Chief Talent Officer of GoldenTree Asset Management (Photo: Business Wire)
    Love will focus on GoldenTree’s human capital strategy, including talent acquisition, development, performance coaching, and mentorship of GoldenTree employees to position the firm for further growth.
  • Love will be based in New York and will report directly to the Executive Committee, chaired by Steve Tananbaum, GoldenTree’s Founder, Managing Partner and Chief Investment Officer.
  • Tananbaum said, “Alysia has worked closely with GoldenTree for almost 5 years and we are excited to have her join the team full-time as our first Chief Talent Officer.

Appointment of Dr. Christopher von Jako as new CEO

Retrieved on: 
Wednesday, June 21, 2023
Xenon, IPO, Partnership, AIM, University, Doctor of Philosophy, Brainsway, 3D, Integra, Radiology, Bates College, MRI, Medtronic, Retirement, Magnetic resonance imaging, Acquisition, Patient, TASE, Pain management, Growth, Ageing, Health, FDA, Medtech, Integra LifeSciences, Multi-monitor, Massachusetts Institute of Technology, Medical device, Management, Nursing, Radionics, Dynatron Radio, Covidien

von Jako”) as Chief Executive Officer and director of the Company, effective immediately.

Key Points: 
  • von Jako”) as Chief Executive Officer and director of the Company, effective immediately.
  • Dr. von Jako succeeds Richard Hullihen, who will be retiring and will be stepping down as a Director of the Company, effective immediately.
  • Since his appointment as CEO in 2017, Richard has overseen significant progress for Polarean.
  • In his most recent executive position, Dr. von Jako served as President and CEO of BrainsWay from 2020 to 2023.

FirstEnergy Names Abigail Phillips Vice President and Chief Risk Officer

Retrieved on: 
Friday, June 9, 2023
Enterprise, New York Bar Association, FirstEnergy, PSEG, Southern California Edison, Duquesne Light Company, Case Western Reserve University, MBA, Multimedia, Enterprise risk management, Bates College, Economics, Organization, Doctorate, Continual improvement process, Phillips, Risk, Climate Solutions Caucus, FE, NYSE, Safety, Management, Electric power

AKRON, Ohio, June 9, 2023 /PRNewswire/ -- FirstEnergy Corp. (NYSE: FE) today announced that Abigail Phillips has been named vice president and chief risk officer, effective July 10. In this role, she will execute a risk program that reflects FirstEnergy's core values and behaviors; implement robust processes, procedures and standards to identify, mitigate and prevent risks across the company; and support efforts by the Board of Directors and senior leadership to implement, review and approve the company's enterprise-wide risk governance and compliance framework.

Key Points: 
  • AKRON, Ohio, June 9, 2023 /PRNewswire/ -- FirstEnergy Corp. (NYSE: FE) today announced that Abigail Phillips has been named vice president and chief risk officer, effective July 10.
  • Phillips will report to Jon Taylor, senior vice president and chief financial officer.
  • Phillips joins FirstEnergy from PSEG, where she most recently served as senior director of Climate Solutions and Business Integration.
  • Prior to PSEG, Phillips was responsible for implementing enterprise risk management programs for Southern California Edison and Duquesne Light.

Tickets For Less Hires Nathan Williford as Senior VP of Product Growth

Retrieved on: 
Wednesday, April 26, 2023
ATBS, Business operations, Sociology, Williford, TicketNetwork, Growth, TFL, Senior, Lend, Bates College, SAAS, Management

OVERLAND PARK, Kan., April 26, 2023 /PRNewswire/ -- Tickets For Less®, one of the fastest-growing event distribution companies in North America, has hired Nathan Williford as Senior Vice President of Product Growth.

Key Points: 
  • OVERLAND PARK, Kan., April 26, 2023 /PRNewswire/ -- Tickets For Less®, one of the fastest-growing event distribution companies in North America, has hired Nathan Williford as Senior Vice President of Product Growth.
  • "After adding ATBS to the TFL family last year, our technology business has continued to grow," said Adam Rossbach, Chief Operating Officer at Tickets For Less.
  • "Bringing Nathan on board is an indication of that growth, and we're thrilled to add his expertise and extensive network in the ticketing industry to improve our product roadmaps and optimize the business."
  • Williford managed teams in product management, software sales, broker services, business development and other departments.

Louis Vachon joins the Board of Directors of BCE Inc.

Retrieved on: 
Friday, October 21, 2022
Essence–energies distinction, Bates College, Ryerson University, Bell, International finance, TSX, National Bank of Canada, Order, University of Ottawa, Flower, The Fletcher School at Tufts University, Risk, Health Management Resources, NYSE, Canadian Business, Research, Financial compensation, United Nations Association, MDA, Bell Let's Talk, Mental health, Bishop's University, Chartered Financial Analyst, University, CPP Investment Board, Tufts University, MONTRAL, National bank, Gastrointestinal tract, Global Citizen Awards, BCE Inc., Les Fusiliers Mont-Royal, Concordia University, United Nations, Board, CEO, J.C. Flowers & Co., Internet, Economics, BCE, Workplace, Molson Coors Beverage Company, United Nations Association in Canada, Bell Canada, Management, Medicine

MONTRAL, Oct. 21, 2022 /CNW Telbec/ - BCE Inc. (TSX: BCE) (NYSE: BCE)today announced the appointment of Louis Vachon as a director of BCE and Bell Canada.

Key Points: 
  • MONTRAL, Oct. 21, 2022 /CNW Telbec/ - BCE Inc. (TSX: BCE) (NYSE: BCE)today announced the appointment of Louis Vachon as a director of BCE and Bell Canada.
  • Mr. Vachon will also join the Board's Management Resources and Compensation Committee and Risk and Pension Fund Committee.
  • "We are honoured that Louis has accepted our invitation to join the BCE Board," said Gordon M. Nixon, Chair of the Board of BCE and Bell Canada.
  • His experience leading National Bank's impressive financial, technological and cultural advancements will be an asset to BCE shareholders."

TowneBank Promotes Morrison and Miller

Retrieved on: 
Thursday, October 13, 2022
Aston, Berkshire Hathaway, Bates College, Insurance, Morrison, Culture, Growth, Business administration, Master of Business Administration, LLC, Income, Business, Old Dominion University, College, Leadership, GLOBE, CSUSB College of Business and Public Administration, Miller, TowneBank Stadium, Management, Towne, Greater Richmond Region, Piedmont (United States)

SUFFOLK, Va., Oct. 13, 2022 (GLOBE NEWSWIRE) -- TowneBank (the Company or Towne) (Nasdaq: TOWN) announced today the promotions of William T. Morrison to president and chief executive officer of Towne Financial Services Group and James M. Miller to chief executive officer of TowneBank Mortgage.

Key Points: 
  • SUFFOLK, Va., Oct. 13, 2022 (GLOBE NEWSWIRE) -- TowneBank (the Company or Towne) (Nasdaq: TOWN) announced today the promotions of William T. Morrison to president and chief executive officer of Towne Financial Services Group and James M. Miller to chief executive officer of TowneBank Mortgage.
  • Miller has served as president of TowneBank Mortgage since 2019 and will continue to hold that title in his new leadership position.
  • We are fortunate to have his continued and expanded leadership at the helm of TowneBank Mortgage and with our mortgage joint ventures.
  • With total assets of $16.86 billion as of June 30, 2022, TowneBank is one of the largest banks headquartered in Virginia.

Rhode Island School of Design to Inaugurate 18th President Crystal Williams on October 7, 2022

Retrieved on: 
Wednesday, October 5, 2022
University, Education, College Hill, Providence, Rhode Island, Bates College, WaterFire, Provost, Sale, Hope, RI, MFA, Education, Parent, Reed College, Multimedia, History, Knowledge, RISD, Student, The New School, Rhode Island School of Design, New Space, Social media, Faculty, Social justice, Boston University, Island School, Trustee, Rhode Island School of Design Museum, Nightclub, Interior design, Management

View the full release here: https://www.businesswire.com/news/home/20221005005105/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20221005005105/en/
    Rhode Island School of Design President Crystal Williams.
  • Credit Jo Sittenfeld
    A teacher, leader, advocate and poet, President Williams believes that education, art and design, and commitments to equity and justice are essential to transforming our society.
  • She was named president by RISDs Board of Trustees on December 16, 2021 following an extensive international search.
  • Crystal Williams believes that education, art and design, and commitments to equity and justice are essential to transforming our society.